Aldosterone regulates sodium reabsorption in epithelial tissues such as the kidney and colon, via a pathway involving the activation of intracellular mineralocorticoid receptors (MR), induction of specific target genes and a subsequent increase in sodium channel activity. Characterized aldosterone target genes in epithelia include the serum and glucocorticoid-regulated kinase 1 and the corticosteroid hormone-induced factor. Endothelin-1 (ET-1) is a potent vasoconstrictor that alters both sodium transport and hydrogen ion secretion in the kidney. Recent studies in a mouse medullary collecting duct cell line and rat A-10 smooth muscle cells have demonstrated an acute response of ET-1 gene expression to aldosterone. In the present study we have investigated the ET-1 gene in vivo as a potential direct aldosterone-regulated target gene in the kidney and colon.
Introduction
Aldosterone promotes sodium reabsorption in epithelial tissues such as the kidney and colon, and plays a critical role in blood pressure homeostasis (1, 2) It also regulates K+ secretion and is implicated in the pathophysiology of cardiac fibrosis and cardiac hypertrophy in end-stage heart failure (3, 4) . Aldosterone regulates nuclear gene transcription in target cells by binding to and activating the mineralocorticoid receptor (MR), which functions as a ligand-activated DNAbound transcription factor (5) . Activated MR is able to bind to specific DNA response elements located in the 5' regulatory regions near the promoters of specific target genes. Activation of MR by aldosterone, however, is complicated by higher circulating levels of glucocorticoids that also bind to MR with the same affinity as aldosterone (6, 7) . This is resolved in many epithelial tissues by the presence of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (HSD2) which rapidly inactivates physiological glucocorticoids allowing aldosterone to bind and activate MR.
In non-epithelial tissues lacking HSD2, the role of aldosterone-mediated effects is not clearly understood and indeed the principle ligand for the MR may, in fact, be cortisol (8) .
Only a few aldosterone-induced target genes have been characterized in detail. These include the α, β, and γ subunits of the epithelial sodium channel (ENaC) (9) . Other characterized targets include the serum and glucocorticoid-regulated kinase-1 (SGK-1) an important mediator of renal sodium homeostasis, corticosteroid hormone-induced factor (CHIF) which regulates the activity of the sodium and potassium-dependent adenosine triphosphatase pump (Na-K-ATPase), the glucocorticoid-induced leucine zipper protein (GILZ), a transcription factor and the Gprotein K-Ras2 (10) (11) (12) . SGK-1 is thought to regulate Na + flux by increasing ENaC activity at the apical surface of epithelial cells. Aldosterone treatment of a rat collecting duct cell line as well as an adrenalectomized rat model demonstrated a rapid induction of SGK-1 mRNA within 30 minutes of treatment (13, 14) . SGK-1 null mice, however, only show mild abnormalities in sodium homeostasis, suggesting that other genomic targets are important for overall regulation of sodium transport (15) . (17) . Endothelin receptor antagonists such as bosentan have been extensively used in the treatment of pulmonary hypertension (18) . Release of ET-1 is stimulated by a number of factors including angiotensin II, antidiuretic hormone (ADH), thrombin, cytokines and reactive oxygen species. ET-1 has other functions apart from vasoconstriction, including roles in the regulation of cellular proliferation (19) . A number of studies have show that endothelin-1 affects renal Na + transport and causes increased acidification in the distal nephron (20, 21) . Several lines of evidence support a role for ET-1 in the pathogenesis of renal and cardiac interstitial fibrosis (22, 23) . For example, ET-1 has been found to activate transcription of the procollagen I promoter via stimulation of ET B receptors; a potential mechanism for aldosterone to increase collagen deposition (24) .
It has been reported recently that aldosterone increases ET-1 expression in both the rat A-10 smooth muscle cell line and in a mouse cortical collecting duct cell line (25, 26) . The study using A-10 cells also showed stimulation of SGK-1 by ET-1 (26) Samples were performed in triplicate with 18S ribosomal RNA used as an endogenous reference gene. The Ct was determined from a curve generated from a plot of cycle number versus fluorescence with a manual threshold set above the background fluorescence of the no template control.
Northern Blot Analysis
Total RNA (15 µg) was separated in 1.2% agarose/2.2M formaldehyde gels and blotted onto Genescreen Plus nylon membranes for northern blot analysis by hybridization with 32 P-labeled DNA probes. To make a rat ET-1 probe, 1ug of total rat RNA was reverse transcribed followed by PCR using the Access Quick™ RT-PCR kit (Promega). The ET-1 primers were; sense: 5'-CTCTGCTGTTTGTGGCTTTC-3' and antisense: 5' CCTCTGCCAGTCTGAACAAG-3', yielding an amplicon of 725 base pairs. PCR products were then ligated into pGEM-T Easy vector (Promega) and then transformed into E.coli JM109 competent cells. A radioactive DNA probe for ET-1 was then generated using the Prime-a Gene Labeling system (Promega) using isolated insert DNA. All filters were hybridized at 42ºC in Ultrahyb buffer (Ambion, Austin, TX) and washed at 45 ºC in 0.1 X SSC, 0.1% SDS 2 times for 15 minutes each. Filters were rehybridized with a 32 P-labeled 323 base pair cDNA fragment of rat 18S rRNA to control for differences in the total RNA loading on agarose gels.
Statistical Analysis
For all northern blot analyses, RNA levels were quantified by densitometric analysis on a Storm
Phosphoimager from Molecular Dynamics (Sunnyvale, CA) using ImageQuant software, and standardized to the expression of 18S rRNA, with statistical significance set at p<0.05.
Statistical analyses for real time PCR were performed using a student t-test. p <0.05 was considered to denote statistically significant differences between treatment groups.
Results

Aldosterone increases endothelin-1 mRNA levels in vivo in the kidney and colon
Total RNA from rat kidney and distal colon was first examined for induction of two known aldosterone target genes, SGK-1 and CHIF, following treatment with aldosterone. Using qRT-PCR, SGK-1 and CHIF mRNA levels in the distal colon increased 4.5 and 4.8 fold one hour after aldosterone treatment respectively ( Figure 1A & 1B) . The levels of induction corresponded to those previously published and demonstrate that aldosterone-mediated effects on target genes were present in the treated animals (10, 14) . To investigate the effect of aldosterone on ET-1 gene expression, qRT-PCR was used to measure ET-1 mRNA levels in rats one hour after treatment with aldosterone. Figure 1C shows a statistically significant 1.8 fold increase in ET-1 mRNA levels in the distal colon one hour after aldosterone treatment while in the kidney from the same animals, mRNA levels for ET-1 increased by ~ 1.7 fold ( Figure 1D ).
Analysis of the endothelin peptide family and endothelin receptor gene expression in the kidney and colon following treatment with aldosterone
We next assessed whether the other isoforms of ET-1 and the receptors ET A and ET B were also induced by aldosterone in the kidney and distal colon, using real-time PCR. Each PCR amplicon was analyzed by agarose gel electrophoresis (Fig.1E ) and their identity verified by DNA sequencing (data not shown). The mRNA levels of ET-2 (Figure 2A ), ET-3 ( Figure 2B ), and ET B ( Figure 2D ) did not change significantly in either the kidney or the distal colon after treatment with aldosterone. ET A mRNA levels increased slightly (1.5 fold) in colon but not in kidney, although this increase did not achieve statistical significance (P=0.055) ( Figure 2C ). To confirm the induction of ET-1 by aldosterone, northern blot analysis was performed with total RNA samples isolated from kidney and colon 1 hr after aldosterone treatment. ET-1 mRNA levels in distal colon were observed to increase 1.5 fold compared to control while aldosterone increased ET-1 mRNA levels by 2 fold in total RNA from the kidney (data not shown). These changes were consistent with those measured using quantitative real-time PCR shown in Figure 1 .
Aldosterone acts via mineralocorticoid receptors to increase endothelin-1 mRNA levels in the kidney and colon
To explore the signaling pathway responsible for the aldosterone-induced increase in ET-1 mRNA, we examined the role of the MR using potassium canrenoate, a MR antagonist.
Adrenalectomized rats were treated with aldosterone with and without potassium canrenoate and expression levels determined after one hour by densitometric analysis of hybridized northern blots. As shown in Figure 3A and 3B, the observed aldosterone-induced increase in ET-1 mRNA in both the kidney and colon was attenuated by co-administration of potassium canrenoate. This demonstrates that MR is involved in mediating the induction of ET-1 mRNA by aldosterone in both kidney and colon.
Time course of induction of endothelin-1 mRNA in the kidney and colon by aldosterone
ET-1 mRNA levels were analyzed in a time course extending up to three hours after treatment with aldosterone by northern blot analysis. In the kidney there was a rapid increase in ET-1 mRNA after only 30 minutes with levels reaching a maximal 2 fold increase after one hour ( Figure 4A ). In the colon, induction of ET-1 mRNA by aldosterone was also maximal at 60 minutes post-injection of aldosterone; with the ET-1 mRNA levels approximately 2.5 those of control rats at time zero. After this time the levels of ET-1 mRNA began to steadily decrease ( Figure 4B ). Overall this demonstrates a rapid and significant induction of ET-1 mRNA by aldosterone in vivo in both the kidney and colon.
Discussion
The effects of aldosterone action on ion channels and transporters such as ENaC and the Na-K-ATPase in the kidney have been well established (2) . The actual gene targets that are directly regulated by aldosterone have been less well defined, particularly in the context of sodium transport and blood pressure regulation. In general, the search for aldosterone induced genes has been a challenge due to the relatively small changes in either mRNA or protein levels of genes involved in the ion transporting pathways. Most characterized aldosterone gene targets such as SGK-1, CHIF, the ENaC subunits and K-Ras2A have only shown modest two to three fold changes shortly after treatment with aldosterone (1, 2). Other targets such as the cardiac AT1 receptor have shown a modest three fold change over a longer three to four week time period after treatment with aldosterone, although this may not reflect a direct transcriptional effect (28) .
A link between mineralocorticoids and ET-1 was first suggested by studies with DOCAsalt hypertensive rats where increased ET-1 immunoreactivity and mRNA levels were detected in aortic and mesenteric arteries 2-3 weeks after the development of hypertension (29, 30) .More recently a gene microarray study using a cortical collecting duct cell line has described several potential aldosterone regulated genes that included ET-1 (25) . This study demonstrated upregulation of ET-1 mRNA by a modest 2.1 fold at one hour after treatment with aldosterone which was blocked by concurrent treatment with the MR antagonist spironolactone. Despite numerous studies involving both aldosterone and ET-1, a direct link between them in vivo has remained uncertain. In this current study, we present data that extends the previous in vitro studies (25, 26) We show firstly, that ET-1 mRNA is increased by aldosterone in a rapid time dependent manner, and secondly, via the use of a co-administered antagonist potassium canrenoate, that the MR is involved in aldosterone-mediated induction of ET-1 mRNA. Previous in vitro studies have used high concentrations of aldosterone (up to 10 -6 M) with the consequence that the induction could be mediated via GR, for which aldosterone has a low but appreciable affinity. An earlier study performed in amphibian kidney-derived A6 cells showed that aldosterone induces SGK-1 activity via GR (13) . Moreover, there have been claims that GR and MR can heterodimerize in vitro and in vivo with resultant GR/MR-mediated effects (33) . In the present study we have investigated the induction of ET-1 mRNA by aldosterone using a relatively low physiological dose of aldosterone (10 ug/100g BW) and also included RU486 with aldosterone treatment to prevent the possibility of GR occupancy and activation by aldosterone.
Our results strongly suggest that ET-1 mRNA levels in the kidney and colon are increased via the classic MR-mediated genomic actions of aldosterone. The time-course studies described in this paper demonstrate that ET-1 is induced by aldosterone within one hour in both kidney and colon, with kidney levels peaking at three fold after two hours. The difference however, tissue-specific gene-targeted mice lacking ET-1 expression specifically in kidney collecting ducts (CDs) are hypertensive and on a high salt diet have reduced sodium excretion (35) . This may reflect other endocrine actions of CD-derived ET-1 or that ET-1 may play a role in the development of the collecting duct that differs from its acute role, and indicates that dissecting the nephron versus vascular actions of ET-1 in the kidney will not be straightforward.
In conclusion, our study shows for the first time in vivo that the ET-1 gene is a direct aldosterone regulated target gene in the kidney and colon in a time-dependent manner. We also demonstrate that induction of ET-1 mRNA by aldosterone is mediated via the MR, most likely via direct interaction with a HRE upstream of the ET-1 gene promoter, although this awaits formal demonstration. Total RNA (15µg) was analyzed in a 1.2% agarose gel and after blotting the filter was hybridized with a probe specific for rat ET-1. Filters were re-probed for 18S rRNA, scanned and quantified as described in the methods section. Statistical analysis was performed using Student's t test. Values are the mean ± SEM (n=3); * P< 0.05. 
